Use access key #2 to skip to page content.
$45.80 1.67 (3.78%)
7/3/2008 1:00 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

1

Avatar flexnexus (28.54) Submitted: 3/15/07 10:46 PM : Underperform Start Price: $53.77 AZN Score: 5.49

While AZN has made a smart deal with Palatin (PTN), I'm generally bearish on big pharma. Lots of legislation is going to come about that will cost them a lot of money.

Report this Post Replies: 0 | Reply

Featured Broker Partners